Latest filing published 13 Mar 2026 for Vital Farms, Inc., €259k. Read the official filing
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Matthew Ohayer in Vital Farms, Inc., where the filings describe the role as chief executive. In total, 58 filings cover trades dated from 10 June 2021 to 5 March 2026.
Market trades split into 3 purchases (€227k) and 46 sales (€201.1M). Sales outweigh purchases by €200.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 4 sales.
The median purchase comes to €76k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 13 March 2026 with an open-market sale (€259k) in Vital Farms, Inc. The last purchase on record was published on 1 December 2021, which is 1,782 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 58 declarations